We report a case of untreated non-Hodgkin's lymphoma with histologic progression over 1 yr from a low-grade, small cleaved follicular center cell lymphoma to a high-grade, small noncleaved follicular center cell lymphoma. Both lymphomas had identical immunoglobulin (Ig) heavy-chain joining gene (JH), kappa light-chain joining gene, and bcl-2 gene rearrangements, indicating the clonal identity of the two tumors. The Ig heavy chain locus on one chromosome 14 was involved in an initial t(14; 18) translocation as shown by comigrating JH and bcl-2 rearrangements. However, the oncogene c-myc was in the germline configuration in the initial lymphoma but had one allele rearranged near the 3' end of exon I in the high-grade tumor; DNA sequence analysis was consistent with a chromosomal breakpoint at that site. The presence of the c-myc rearrangement in the high-grade tumor suggest a role for c-myc in the clonal evolution of the low-grade tumor into a more aggressive lymphoma. The coexistence of both bcl-2 gene and c-myc oncogene rearrangements in the same tumor is unusual, with only a few cases reported. Furthermore, this case is unique in the direct demonstration of the histologic and clinical progression of a human lymphoma associated with the sequential rearrangement of the bcl-2 gene and the c-myc oncogene.
J T Lee, D J Innes Jr, M E Williams
Title and authors | Publication | Year |
---|---|---|
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
A Strasser, S Cory, JM Adams |
The EMBO Journal | 2011 |
Atypical burkitt's lymphoma transforming from follicular lymphoma
YY Hwang, F Loong, LP Chung, CS Chim |
Diagnostic Pathology | 2011 |
Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large b-cell lymphomas
S Guney, P Bertrand, F Jardin, P Ruminy, JP Kerckaert, H Tilly, C Bastard |
Genes, Chromosomes and Cancer | 2011 |
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome
S Li, P Lin, LE Fayad, PA Lennon, RN Miranda, CC Yin, E Lin, LJ Medeiros |
Modern Pathology | 2011 |
Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells
M Nakagawa, S Tsuzuki, K Honma, O Taguchi, M Seto |
Haematologica | 2011 |